Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/19/2025
U.S. Tariffs Pressure Mounting, Japanese Pharma Looks East for Growth ...
8/19/2025
Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...
8/18/2025
Tarlatamab Shows Promising Results in Chinese Phase 2 Trial for Heavil...
8/18/2025
Pleryon Completes First Closing of Series A Financing
8/15/2025
NHSA Issues Interim Measures for Disease-Based Medical Insurance Payme...
8/14/2025
Amphastar Strikes Major Licensing Deal to Supercharge Peptide Pipeline
8/14/2025
YolTech Unveils Breakthru In Vivo Editing of Human Blood Stem Cells
8/14/2025
Remegen's Telitacicept Achieves Phase III Success
8/14/2025
CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines for Drug Qualit...
8/13/2025
Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...
8/13/2025
NHSA Publishes Preliminary Review Results for 2025 NRDL Adjustments wi...
8/13/2025
Summit Skips Quarterly Earnings Call amid Strategic Shifts and BLA Pla...
8/13/2025
MNCs Target China's New Commercial Insurance Catalog to Gain Ground
8/12/2025
Akeso Doses First Patient in Phase III Trial of Ivonescimab
8/11/2025
Novo Nordisk Reports Solid Growth in China Amid Global Expansion in H1...
8/8/2025
Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...
8/8/2025
AstraZeneca Expands Use of Fasenra in China
8/8/2025
Minghui Raises $131M to Accelerate Clinical and Commercial Expansion
8/8/2025
Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...
8/8/2025
Triple Squeeze Threatens China's Global Drug Push
8/8/2025
Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC
8/8/2025
Wuxi Apptec Strengthens European Foothold with Luxembourg Expansion Am...
8/8/2025
Recent Executive Moves
8/8/2025
Pharma MNCs in China H1/2025 – Mature Products Exit, Top Performers R...
8/8/2025
China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...
8/7/2025
Innovation through Talent: How Leadership Is Evolving in China's Life ...
8/6/2025
Big Pharma Provides Lifeline to Chinese Companies Struggling To Surviv...
8/6/2025
Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...
8/6/2025
MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial
8/6/2025
China Launches 11th National VBP Round with New Flexibility for Hospit...
Page:
3
/
367
Total number of articles:
10986
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit